Shattuck Labs reports Phase 1 data for SL-325, sets Phase 2b start for Q3 2026Aug 11Quarterly updateShattuck Labs, Inc.SL-325
Shattuck Labs registers Phase 2 trial of SL-325 in Crohn's diseaseAug 10Trial updateShattuck Labs, Inc.SL-325
Sign inSign in